HeartFlow anticipates rolling out its computed tomography-based coronary fractional flow reserve software (FFRCT) in the U.S. very soon, following an imminent FDA decision on the system. The firm hopes its cloud-based software system, which relies on advanced computational fluid dynamics algorithms and CT imaging, will offer an enhancement on catheter-based FFR to interventional cardiologists.
HeartFlow Inc. is applying complex computation fluid dynamics to the challenges of interventional cardiology with computed tomography-based coronary fractional flow reserve software system.
The firm expects FDA go-ahead of its FFRCT system very soon, after which the company will gradually roll it out in the U